ONTOLOGY REPORT - ANNOTATIONS
| Term: | zinc atom |
|
| Accession: | CHEBI:27363
|
browse the term
|
| Definition: | A zinc group element atom that has formula Zn. |
| Synonyms: | related_synonym: | 30Zn; InChI=1S/Zn; InChIKey=HCHKCACWOHOZIP-UHFFFAOYSA-N; Zink; Zn; cinc; zinc; zincum |
| | xref_casrn: | 7440-66-6 |
| | xref: | ChEBI:C00038 "KEGG COMPOUND"; ChemIDplus:7440-66-6 "CAS Registry Number"; Gmelin:16321 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D015032 |
| | xref: | WebElements:Zn "WebElements" |
|
|
zinc atom
|
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
affects expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
affects expression |
EXP |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
affects expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
EXP |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
multiple interactions |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
increases expression |
ISO |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
increases expression |
EXP |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
EXP |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
decreases activity |
ISO |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
affects binding |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
EXP |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Adam12 |
ADAM metallopeptidase domain 12 |
|
multiple interactions |
ISO |
1 |
193,384,457 |
193,650,892 |
RGD:6480464 |
CTD |
| G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
decreases expression |
ISO |
15 |
45,449,574 |
45,491,663 |
RGD:6480464 |
CTD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
multiple interactions |
ISO |
1 |
199,780,772 |
199,791,855 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
multiple interactions |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
multiple interactions |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
multiple interactions |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
|
decreases expression |
EXP |
17 |
77,316,456 |
77,332,903 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
decreases expression |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
affects activity |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
affects binding |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
|
affects binding |
ISO |
5 |
64,092,017 |
64,096,576 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
affects expression |
EXP |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
affects expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa10 |
annexin A10 |
|
multiple interactions |
ISO |
16 |
30,713,142 |
30,782,020 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
affects expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
affects expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
|
decreases expression |
EXP |
4 |
159,033,170 |
159,048,108 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects binding |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects binding |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases secretion |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects binding |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases degradation |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
increases expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arhgef9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
|
multiple interactions |
ISO |
X |
82,594,347 |
82,754,179 |
RGD:6480464 |
CTD |
| G |
Arl4c |
ADP-ribosylation factor-like 4C |
|
multiple interactions |
ISO |
9 |
87,617,584 |
87,663,028 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
decreases localization |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
affects localization |
ISO |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
decreases expression |
EXP |
1 |
159,586,246 |
159,590,797 |
RGD:6480464 |
CTD |
| G |
Art3 |
ADP-ribosyltransferase 3 |
|
increases expression |
EXP |
14 |
17,198,267 |
17,280,642 |
RGD:6480464 |
CTD |
| G |
Aspa |
aspartoacylase |
|
affects binding |
ISO |
10 |
60,178,509 |
60,199,207 |
RGD:6480464 |
CTD |
| G |
Aspa |
aspartoacylase |
|
affects binding |
EXP |
10 |
60,178,509 |
60,199,207 |
RGD:6480464 |
CTD |
| G |
Aspa |
aspartoacylase |
|
affects binding |
ISO |
10 |
60,178,509 |
60,199,207 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
multiple interactions |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects expression |
ISO |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
multiple interactions |
ISO |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atg12 |
autophagy related 12 |
|
multiple interactions |
ISO |
18 |
40,933,793 |
40,943,970 |
RGD:6480464 |
CTD |
| G |
Atg5 |
autophagy related 5 |
|
multiple interactions |
ISO |
20 |
48,273,977 |
48,366,743 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2c1 |
ATPase, Ca++ transporting, type 2C, member 1 |
|
increases expression |
EXP |
8 |
110,516,092 |
110,603,620 |
RGD:6480464 |
CTD |
| G |
Atp5h |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d |
|
decreases expression |
EXP |
10 |
105,474,107 |
105,499,413 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
increases abundance |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atxn3 |
ataxin 3 |
|
affects folding |
ISO |
6 |
126,196,043 |
126,229,844 |
RGD:6480464 |
CTD |
| G |
Atxn3 |
ataxin 3 |
|
multiple interactions |
ISO |
6 |
126,196,043 |
126,229,844 |
RGD:6480464 |
CTD |
| G |
Atxn3 |
ataxin 3 |
|
affects folding |
ISO |
6 |
126,196,043 |
126,229,844 |
RGD:6480464 |
CTD |
| G |
Atxn3 |
ataxin 3 |
|
multiple interactions |
ISO |
6 |
126,196,043 |
126,229,844 |
RGD:6480464 |
CTD |
| G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
|
decreases expression |
EXP |
8 |
26,333,218 |
26,359,068 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
decreases expression |
ISO |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
increases expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
ISO |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Blk |
B lymphoid tyrosine kinase |
|
increases expression |
ISO |
15 |
42,643,847 |
42,682,793 |
RGD:6480464 |
CTD |
| G |
Btbd2 |
BTB (POZ) domain containing 2 |
|
affects expression |
ISO |
7 |
10,568,395 |
10,585,686 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
increases expression |
ISO |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases expression |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases expression |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
increases expression |
EXP |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Cald1 |
caldesmon 1 |
|
increases expression |
ISO |
4 |
62,087,364 |
62,156,855 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Capn11 |
calpain 11 |
|
multiple interactions |
ISO |
9 |
10,944,080 |
10,965,592 |
RGD:6480464 |
CTD |
| G |
Capn9 |
calpain 9 |
|
multiple interactions |
ISO |
19 |
54,759,009 |
54,796,390 |
RGD:6480464 |
CTD |
| G |
Car14 |
carbonic anhydrase 14 |
|
multiple interactions |
ISO |
2 |
190,683,916 |
190,690,229 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
multiple interactions |
ISO |
10 |
70,380,498 |
70,383,276 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
multiple interactions |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
EXP |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccs |
copper chaperone for superoxide dismutase |
|
multiple interactions |
EXP |
1 |
207,429,928 |
207,450,996 |
RGD:6480464 |
CTD |
| G |
Ccs |
copper chaperone for superoxide dismutase |
|
affects binding |
ISO |
1 |
207,429,928 |
207,450,996 |
RGD:6480464 |
CTD |
| G |
Cd22 |
CD22 molecule |
|
increases expression |
ISO |
1 |
85,923,707 |
85,938,567 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
multiple interactions |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
multiple interactions |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
increases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc42bpb |
CDC42 binding protein kinase beta (DMPK-like) |
|
affects expression |
ISO |
6 |
136,053,885 |
136,136,234 |
RGD:6480464 |
CTD |
| G |
Cdc42ep2 |
CDC42 effector protein (Rho GTPase binding) 2 |
|
multiple interactions |
ISO |
1 |
208,548,137 |
208,556,965 |
RGD:6480464 |
CTD |
| G |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
|
multiple interactions |
ISO |
6 |
2,111,458 |
2,132,242 |
RGD:6480464 |
CTD |
| G |
Cdc45 |
cell division cycle 45 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdca4 |
cell division cycle associated 4 |
|
multiple interactions |
ISO |
6 |
137,818,816 |
137,828,119 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
multiple interactions |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
increases expression |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases response to substance |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases expression |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Champ1 |
chromosome alignment maintaining phosphoprotein 1 |
|
multiple interactions |
ISO |
16 |
80,569,713 |
80,573,705 |
RGD:6480464 |
CTD |
| G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
|
multiple interactions |
ISO |
1 |
128,609,727 |
128,720,325 |
RGD:6480464 |
CTD |
| G |
Chmp1b |
charged multivesicular body protein 1B |
|
multiple interactions |
ISO |
18 |
63,715,066 |
63,717,596 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Chsy1 |
chondroitin sulfate synthase 1 |
|
multiple interactions |
ISO |
1 |
120,539,002 |
120,600,102 |
RGD:6480464 |
CTD |
| G |
Chtop |
chromatin target of PRMT1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cic |
capicua transcriptional repressor |
|
increases expression |
ISO |
1 |
80,558,096 |
80,569,432 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
affects expression |
ISO |
10 |
5,087,174 |
5,133,418 |
RGD:6480464 |
CTD |
| G |
Ckap4 |
cytoskeleton-associated protein 4 |
|
increases expression |
ISO |
7 |
21,360,351 |
21,368,448 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
|
multiple interactions |
ISO |
17 |
47,672,292 |
47,715,697 |
RGD:6480464 |
CTD |
| G |
Cmklr1 |
chemokine-like receptor 1 |
|
multiple interactions |
ISO |
12 |
44,056,527 |
44,061,043 |
RGD:6480464 |
CTD |
| G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
|
increases expression |
ISO |
4 |
122,033,037 |
122,041,891 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
decreases expression |
EXP |
2 |
218,044,803 |
218,075,914 |
RGD:6480464 |
CTD |
| G |
Cntn6 |
contactin 6 |
|
multiple interactions |
ISO |
4 |
140,078,007 |
140,450,348 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Comp |
cartilage oligomeric matrix protein |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cox17 |
COX17 cytochrome c oxidase copper chaperone |
|
decreases expression |
EXP |
11 |
64,183,573 |
64,185,985 |
RGD:6480464 |
CTD |
| G |
Cox8a |
cytochrome c oxidase subunit VIIIa |
|
decreases expression |
EXP |
1 |
209,886,141 |
209,888,462 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
increases expression |
ISO |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
affects expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
multiple interactions |
ISO |
8 |
43,943,971 |
43,981,609 |
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csn2 |
casein beta |
|
affects expression |
EXP |
14 |
21,847,981 |
21,855,216 |
RGD:6480464 |
CTD |
| G |
Csrnp2 |
cysteine-serine-rich nuclear protein 2 |
|
multiple interactions |
ISO |
7 |
139,182,243 |
139,198,084 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
increases expression |
EXP |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
increases expression |
ISO |
13 |
44,582,911 |
44,605,241 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
EXP |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
decreases activity |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
decreases expression |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cttn |
cortactin |
|
increases expression |
EXP |
1 |
204,865,768 |
204,901,221 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
increases activity |
ISO |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
multiple interactions |
ISO |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
decreases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
EXP |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
decreases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
affects expression |
ISO |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases expression |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
decreases expression |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
affects expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
increases expression |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
ISO |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dlgap5 |
discs, large (Drosophila) homolog-associated protein 5 |
|
increases expression |
ISO |
15 |
23,340,955 |
23,375,755 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
multiple interactions |
EXP |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drp2 |
dystrophin related protein 2 |
|
decreases expression |
ISO |
X |
121,881,801 |
121,929,386 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
multiple interactions |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
decreases expression |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
multiple interactions |
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:6480464 |
CTD |
| G |
Dusp16 |
dual specificity phosphatase 16 |
|
multiple interactions |
ISO |
4 |
171,620,395 |
171,667,593 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
decreases expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
decreases expression |
ISO |
6 |
135,318,083 |
135,391,459 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
affects binding |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
increases expression |
EXP |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Efna4 |
ephrin A4 |
|
multiple interactions |
ISO |
2 |
181,521,270 |
181,525,521 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases import |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases uptake |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egln1 |
EGL nine homolog 1 (C. elegans) |
|
multiple interactions |
ISO |
19 |
55,080,670 |
55,118,226 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
affects expression |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
multiple interactions |
ISO |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
decreases activity |
ISO |
12 |
11,039,139 |
11,072,708 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
EXP |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Emid1 |
EMI domain containing 1 |
|
increases expression |
ISO |
14 |
85,765,394 |
85,801,932 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
affects binding |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
affects expression |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
|
decreases expression |
ISO |
2 |
26,073,852 |
26,078,618 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
increases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
increases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
increases expression |
EXP |
2 |
219,591,502 |
219,605,097 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
increases expression |
EXP |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
decreases expression |
ISO |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
affects activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
multiple interactions |
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
increases expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf16 |
fibroblast growth factor 16 |
|
multiple interactions |
ISO |
X |
93,870,484 |
93,880,067 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
multiple interactions |
ISO |
2 |
192,463,087 |
192,489,803 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
multiple interactions |
EXP |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
multiple interactions |
EXP |
6 |
99,427,967 |
99,511,373 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases phosphorylation |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxd1 |
forkhead box D1 |
|
increases expression |
ISO |
2 |
28,944,067 |
28,945,665 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases phosphorylation |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
affects localization |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
multiple interactions |
ISO |
X |
89,332,278 |
89,338,835 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
increases phosphorylation |
ISO |
X |
89,332,278 |
89,338,835 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
affects activity |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gabarapl2 |
GABA(A) receptor-associated protein like 2 |
|
affects expression |
ISO |
19 |
41,880,238 |
41,891,074 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
EXP |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
multiple interactions |
EXP |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrd |
gamma-aminobutyric acid (GABA) A receptor, delta |
|
affects expression |
EXP |
5 |
172,203,064 |
172,214,960 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
affects response to substance |
EXP |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
EXP |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects binding |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
decreases expression |
EXP |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
EXP |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
increases expression |
EXP |
1 |
220,824,976 |
220,829,980 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
multiple interactions |
ISO |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
multiple interactions |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
increases expression |
EXP |
4 |
149,622,566 |
149,628,111 |
RGD:6480464 |
CTD |
| G |
Gif |
gastric intrinsic factor |
|
multiple interactions |
ISO |
1 |
214,519,329 |
214,533,578 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
affects binding |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
decreases response to substance |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
affects response to substance |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
increases activity |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
decreases activity |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
multiple interactions |
ISO |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
affects expression |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
affects expression |
EXP |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
increases expression |
ISO |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases activity |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases activity |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
multiple interactions |
EXP |
16 |
80,979,323 |
80,991,796 |
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
decreases expression |
EXP |
16 |
80,979,323 |
80,991,796 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Guca2b |
guanylate cyclase activator 2B |
|
increases expression |
EXP |
5 |
140,237,184 |
140,239,234 |
RGD:6480464 |
CTD |
| G |
Guca2b |
guanylate cyclase activator 2B |
|
increases expression |
EXP |
5 |
140,237,184 |
140,239,234 |
RGD:6480464 |
CTD |
| G |
Guca2b |
guanylate cyclase activator 2B |
|
multiple interactions |
EXP |
5 |
140,237,184 |
140,239,234 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases secretion |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac4 |
histone deacetylase 4 |
|
multiple interactions |
ISO |
9 |
91,147,435 |
91,389,810 |
RGD:6480464 |
CTD |
| G |
Hdac6 |
histone deacetylase 6 |
|
multiple interactions |
ISO |
X |
26,585,852 |
26,606,999 |
RGD:6480464 |
CTD |
| G |
Hdac8 |
histone deacetylase 8 |
|
affects binding |
ISO |
X |
90,336,001 |
90,544,511 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
decreases expression |
EXP |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
multiple interactions |
EXP |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
EXP |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
affects abundance |
ISO |
17 |
48,469,927 |
48,478,502 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
multiple interactions |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
affects expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hoxc10 |
homeo box C10 |
|
decreases expression |
ISO |
7 |
141,717,910 |
141,734,613 |
RGD:6480464 |
CTD |
| G |
Hrg |
histidine-rich glycoprotein |
|
increases activity |
ISO |
11 |
80,248,578 |
80,264,179 |
RGD:6480464 |
CTD |
| G |
Hrg |
histidine-rich glycoprotein |
|
multiple interactions |
ISO |
11 |
80,248,578 |
80,264,179 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases activity |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases activity |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
affects abundance |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
multiple interactions |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
affects expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
affects expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
increases expression |
EXP |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
multiple interactions |
EXP |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifna1 |
interferon, alpha 1 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases uptake |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
affects expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases phosphorylation |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
decreases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases degradation |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
affects expression |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
multiple interactions |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igll1 |
immunoglobulin lambda-like polypeptide 1 |
|
affects expression |
ISO |
11 |
86,159,013 |
86,162,005 |
RGD:6480464 |
CTD |
| G |
Igll1 |
immunoglobulin lambda-like polypeptide 1 |
|
multiple interactions |
ISO |
11 |
86,159,013 |
86,162,005 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
affects expression |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
multiple interactions |
ISO |
4 |
96,929,755 |
96,995,733 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
multiple interactions |
ISO |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
|
multiple interactions |
ISO |
X |
125,013,154 |
126,352,850 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
affects expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
affects expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
increases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
multiple interactions |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il3 |
interleukin 3 |
|
multiple interactions |
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects abundance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects abundance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases uptake |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
multiple interactions |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Il9r |
interleukin 9 receptor |
|
affects expression |
ISO |
10 |
15,678,793 |
15,690,250 |
RGD:6480464 |
CTD |
| G |
Il9r |
interleukin 9 receptor |
|
multiple interactions |
ISO |
10 |
15,678,793 |
15,690,250 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
affects binding |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
affects binding |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
affects expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
multiple interactions |
ISO |
7 |
59,408,198 |
59,467,821 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
affects expression |
ISO |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
multiple interactions |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
increases expression |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
decreases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
multiple interactions |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
increases expression |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
decreases expression |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin, beta 8 |
|
increases expression |
ISO |
6 |
146,494,978 |
146,573,064 |
RGD:6480464 |
CTD |
| G |
Itm2c |
integral membrane protein 2C |
|
increases expression |
ISO |
9 |
84,611,756 |
84,625,391 |
RGD:6480464 |
CTD |
| G |
Itprip |
inositol 1,4,5-trisphosphate receptor interacting protein |
|
multiple interactions |
ISO |
1 |
253,285,635 |
253,287,846 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
EXP |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jak3 |
Janus kinase 3 |
|
increases expression |
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases activity |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kat8 |
K (lysine) acetyltransferase 8 |
|
increases expression |
ISO |
1 |
187,198,682 |
187,210,962 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
EXP |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression |
EXP |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
|
increases expression |
EXP |
1 |
203,383,401 |
203,803,687 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
|
increases expression |
EXP |
1 |
203,383,401 |
203,803,687 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
multiple interactions |
ISO |
18 |
27,100,044 |
27,108,530 |
RGD:6480464 |
CTD |
| G |
Klf12 |
Kruppel-like factor 12 |
|
multiple interactions |
ISO |
15 |
83,686,143 |
84,046,291 |
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
increases expression |
EXP |
4 |
124,714,395 |
124,726,991 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
EXP |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klk5 |
kallikrein related-peptidase 5 |
|
multiple interactions |
ISO |
1 |
94,273,869 |
94,281,384 |
RGD:6480464 |
CTD |
| G |
Klk5 |
kallikrein related-peptidase 5 |
|
decreases activity |
ISO |
1 |
94,273,869 |
94,281,384 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
decreases activity |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Klrb1 |
killer cell lectin-like receptor subfamily B, member 1 |
|
affects expression |
ISO |
4 |
166,253,201 |
166,271,896 |
RGD:6480464 |
CTD |
| G |
L2hgdh |
L-2-hydroxyglutarate dehydrogenase |
|
increases expression |
ISO |
6 |
91,730,715 |
91,771,825 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
increases expression |
ISO |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
increases expression |
ISO |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
multiple interactions |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Larp4b |
La ribonucleoprotein domain family, member 4B |
|
multiple interactions |
ISO |
17 |
71,931,605 |
72,010,103 |
RGD:6480464 |
CTD |
| G |
Lats2 |
large tumor suppressor 2 |
|
multiple interactions |
ISO |
15 |
36,720,000 |
36,761,065 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
affects expression |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
increases expression |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lmo7 |
LIM domain 7 |
|
multiple interactions |
ISO |
15 |
85,710,975 |
85,928,469 |
RGD:6480464 |
CTD |
| G |
LOC501282 |
similar to lymphocyte antigen 6 complex, locus E ligand |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
affects expression |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
affects expression |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
increases expression |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
decreases expression |
EXP |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
multiple interactions |
ISO |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
increases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
increases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases ubiquitination |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
multiple interactions |
ISO |
13 |
45,895,832 |
45,931,421 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
multiple interactions |
ISO |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mid1 |
midline 1 (Opitz/BBB syndrome) |
|
affects binding |
ISO |
X |
44,751,950 |
44,879,999 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
multiple interactions |
ISO |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
affects binding |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
decreases expression |
EXP |
7 |
116,359,466 |
116,364,146 |
RGD:6480464 |
CTD |
| G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
|
decreases expression |
ISO |
1 |
213,763,696 |
213,770,756 |
RGD:6480464 |
CTD |
| G |
Ms4a6b |
membrane-spanning 4-domains, subfamily A, member 6B |
|
decreases expression |
ISO |
1 |
214,160,470 |
214,182,384 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
multiple interactions |
ISO |
10 |
15,017,162 |
15,022,823 |
RGD:6480464 |
CTD |
| G |
Mst4 |
serine/threonine protein kinase MST4 |
|
decreases expression |
ISO |
X |
137,577,961 |
137,627,511 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
multiple interactions |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects binding |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects binding |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects binding |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects abundance |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects response to substance |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects abundance |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
affects binding |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mta2 |
metastasis associated 1 family, member 2 |
|
decreases expression |
ISO |
1 |
211,618,426 |
211,627,147 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
decreases response to substance |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases activity |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases response to substance |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases expression |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases expression |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
affects binding |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases activity |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
increases expression |
EXP |
16 |
54,611,502 |
54,664,075 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
multiple interactions |
ISO |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression |
EXP |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Mzf1 |
myeloid zinc finger 1 |
|
multiple interactions |
ISO |
1 |
72,870,145 |
72,881,239 |
RGD:6480464 |
CTD |
| G |
Nap1l3 |
nucleosome assembly protein 1-like 3 |
|
multiple interactions |
ISO |
X |
112,244,521 |
112,247,319 |
RGD:6480464 |
CTD |
| G |
Ndufaf5 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 |
|
decreases expression |
ISO |
3 |
128,353,866 |
128,384,213 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
decreases expression |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
multiple interactions |
ISO |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nf1 |
neurofibromin 1 |
|
decreases expression |
ISO |
10 |
65,574,833 |
65,766,305 |
RGD:6480464 |
CTD |
| G |
Nf2 |
neurofibromin 2 (merlin) |
|
decreases expression |
ISO |
14 |
85,415,142 |
85,508,807 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nfatc4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
increases localization |
ISO |
15 |
33,969,774 |
33,978,848 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
multiple interactions |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects localization |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbil1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
|
multiple interactions |
ISO |
20 |
3,629,246 |
3,644,222 |
RGD:6480464 |
CTD |
| G |
Ngb |
neuroglobin |
|
decreases uptake |
ISO |
6 |
111,231,188 |
111,236,255 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
affects binding |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
decreases expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nmnat1 |
nicotinamide nucleotide adenylyltransferase 1 |
|
decreases response to substance |
ISO |
5 |
166,548,899 |
166,567,266 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects localization |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases expression |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
affects expression |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects binding |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
multiple interactions |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
ISO |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
affects binding |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcdha2 |
protocadherin alpha 2 |
|
multiple interactions |
ISO |
18 |
29,670,538 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
multiple interactions |
ISO |
12 |
19,672,505 |
19,678,821 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
affects expression |
EXP |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
affects binding |
ISO |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
increases expression |
EXP |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
increases expression |
EXP |
5 |
26,234,414 |
26,240,301 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
decreases expression |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Peg3 |
paternally expressed 3 |
|
decreases expression |
ISO |
1 |
65,513,912 |
65,526,040 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
decreases expression |
EXP |
13 |
43,624,838 |
43,652,660 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
decreases expression |
EXP |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
increases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
affects expression |
EXP |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pik3r4 |
phosphoinositide-3-kinase, regulatory subunit 4 |
|
increases expression |
ISO |
8 |
110,741,833 |
110,790,709 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
increases expression |
EXP |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pkia |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
|
increases expression |
EXP |
2 |
96,524,399 |
96,548,144 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pmch |
pro-melanin-concentrating hormone |
|
increases expression |
EXP |
7 |
24,778,133 |
24,779,449 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
increases expression |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Pou4f3 |
POU class 4 homeobox 3 |
|
multiple interactions |
ISO |
18 |
35,600,462 |
35,603,054 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
decreases expression |
EXP |
6 |
8,319,544 |
8,373,795 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
affects binding |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
affects binding |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
multiple interactions |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
multiple interactions |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prpsap2 |
phosphoribosyl pyrophosphate synthetase-associated protein 2 |
|
increases expression |
EXP |
10 |
47,890,667 |
47,925,430 |
RGD:6480464 |
CTD |
| G |
Psen1 |
presenilin 1 |
|
increases uptake |
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:6480464 |
CTD |
| G |
Psen1 |
presenilin 1 |
|
increases uptake |
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:6480464 |
CTD |
| G |
Psmd4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression |
EXP |
2 |
189,933,161 |
189,942,421 |
RGD:6480464 |
CTD |
| G |
Psph |
phosphoserine phosphatase |
|
affects binding |
ISO |
12 |
27,969,748 |
27,984,318 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
increases expression |
ISO |
3 |
11,521,214 |
11,528,395 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
increases expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
|
multiple interactions |
ISO |
6 |
143,787,884 |
144,549,042 |
RGD:6480464 |
CTD |
| G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
|
decreases expression |
ISO |
8 |
53,880,701 |
53,887,711 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
multiple interactions |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
Pxk |
PX domain containing serine/threonine kinase |
|
increases expression |
EXP |
15 |
18,744,748 |
18,815,195 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
multiple interactions |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
multiple interactions |
ISO |
2 |
157,332,213 |
157,367,137 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
affects expression |
ISO |
3 |
103,371,879 |
103,433,010 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rfwd3 |
ring finger and WD repeat domain 3 |
|
multiple interactions |
ISO |
19 |
41,190,144 |
41,222,888 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
multiple interactions |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
RGD1306063 |
similar to HT021 |
|
decreases expression |
ISO |
15 |
14,395,450 |
14,412,116 |
RGD:6480464 |
CTD |
| G |
RGD1309594 |
similar to RIKEN cDNA 1810043G02; DNA segment, Chr 10, Johns Hopkins University 13, expressed |
|
increases expression |
ISO |
20 |
11,034,059 |
11,040,919 |
RGD:6480464 |
CTD |
| G |
RGD1359529 |
similar to chromosome 1 open reading frame 63 |
|
multiple interactions |
ISO |
5 |
153,698,946 |
153,702,685 |
RGD:6480464 |
CTD |
| G |
RGD1560065 |
similar to RIKEN cDNA 2410004B18 |
|
multiple interactions |
ISO |
2 |
244,129,298 |
244,135,911 |
RGD:6480464 |
CTD |
| G |
RGD1560065 |
similar to RIKEN cDNA 2410004B18 |
|
decreases expression |
ISO |
2 |
244,129,298 |
244,135,911 |
RGD:6480464 |
CTD |
| G |
RGD1562218 |
similar to RIKEN cDNA 0610039J04 |
|
decreases expression |
ISO |
19 |
55,019,196 |
55,033,524 |
RGD:6480464 |
CTD |
| G |
RGD1563888 |
similar to DNA segment, Chr 16, ERATO Doi 472, expressed |
|
multiple interactions |
ISO |
11 |
17,446,314 |
17,476,625 |
RGD:6480464 |
CTD |
| G |
Rgs11 |
regulator of G-protein signaling 11 |
|
multiple interactions |
ISO |
10 |
15,469,922 |
15,478,157 |
RGD:6480464 |
CTD |
| G |
Rgs13 |
regulator of G-protein signaling 13 |
|
multiple interactions |
ISO |
13 |
58,016,245 |
58,042,762 |
RGD:6480464 |
CTD |
| G |
Rgs19 |
regulator of G-protein signaling 19 |
|
decreases expression |
EXP |
3 |
170,839,907 |
170,844,746 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
multiple interactions |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
affects binding |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
affects binding |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
multiple interactions |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
Samd4a |
sterile alpha motif domain containing 4A |
|
multiple interactions |
ISO |
15 |
22,847,701 |
22,952,499 |
RGD:6480464 |
CTD |
| G |
Samd8 |
sterile alpha motif domain containing 8 |
|
multiple interactions |
ISO |
15 |
2,569,527 |
2,612,834 |
RGD:6480464 |
CTD |
| G |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
|
increases expression |
ISO |
11 |
14,633,494 |
14,683,788 |
RGD:6480464 |
CTD |
| G |
Sardh |
sarcosine dehydrogenase |
|
decreases expression |
ISO |
3 |
6,076,166 |
6,142,565 |
RGD:6480464 |
CTD |
| G |
Sbno1 |
strawberry notch homolog 1 (Drosophila) |
|
increases expression |
ISO |
12 |
33,289,890 |
33,345,306 |
RGD:6480464 |
CTD |
| G |
Scara3 |
scavenger receptor class A, member 3 |
|
decreases expression |
ISO |
15 |
45,344,539 |
45,377,576 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scfd2 |
sec1 family domain containing 2 |
|
decreases expression |
ISO |
14 |
36,058,698 |
36,386,253 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
increases expression |
EXP |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
affects transport |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
multiple interactions |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
affects binding |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Serpina5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
|
multiple interactions |
ISO |
6 |
128,156,901 |
128,161,334 |
RGD:6480464 |
CTD |
| G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
multiple interactions |
ISO |
1 |
204,399,856 |
204,855,474 |
RGD:6480464 |
CTD |
| G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
|
affects binding |
EXP |
7 |
127,817,026 |
127,877,875 |
RGD:6480464 |
CTD |
| G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
|
affects folding |
EXP |
7 |
127,817,026 |
127,877,875 |
RGD:6480464 |
CTD |
| G |
Siva1 |
SIVA1, apoptosis-inducing factor |
|
affects binding |
ISO |
6 |
137,631,408 |
137,635,724 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
decreases expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
affects expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases transport |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases uptake |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
decreases secretion |
ISO |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases transport |
ISO |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases secretion |
ISO |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
increases transport |
ISO |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
multiple interactions |
EXP |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
increases transport |
EXP |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
increases transport |
ISO |
3 |
109,643,714 |
109,665,750 |
RGD:6480464 |
CTD |
| G |
Slc30a5 |
solute carrier family 30 (zinc transporter), member 5 |
|
increases transport |
ISO |
2 |
31,607,557 |
31,637,655 |
RGD:6480464 |
CTD |
| G |
Slc30a5 |
solute carrier family 30 (zinc transporter), member 5 |
|
multiple interactions |
ISO |
2 |
31,607,557 |
31,637,655 |
RGD:6480464 |
CTD |
| G |
Slc30a5 |
solute carrier family 30 (zinc transporter), member 5 |
|
decreases expression |
ISO |
2 |
31,607,557 |
31,637,655 |
RGD:6480464 |
CTD |
| G |
Slc30a6 |
solute carrier family 30 (zinc transporter), member 6 |
|
increases transport |
ISO |
6 |
20,956,126 |
20,985,614 |
RGD:6480464 |
CTD |
| G |
Slc30a6 |
solute carrier family 30 (zinc transporter), member 6 |
|
multiple interactions |
ISO |
6 |
20,956,126 |
20,985,614 |
RGD:6480464 |
CTD |
| G |
Slc30a7 |
solute carrier family 30 (zinc transporter), member 7 |
|
increases transport |
ISO |
2 |
212,088,266 |
212,162,896 |
RGD:6480464 |
CTD |
| G |
Slc30a7 |
solute carrier family 30 (zinc transporter), member 7 |
|
increases expression |
ISO |
2 |
212,088,266 |
212,162,896 |
RGD:6480464 |
CTD |
| G |
Slc30a7 |
solute carrier family 30 (zinc transporter), member 7 |
|
multiple interactions |
ISO |
2 |
212,088,266 |
212,162,896 |
RGD:6480464 |
CTD |
| G |
Slc30a8 |
solute carrier family 30 (zinc transporter), member 8 |
|
increases abundance |
ISO |
7 |
88,583,770 |
88,617,145 |
RGD:6480464 |
CTD |
| G |
Slc30a8 |
solute carrier family 30 (zinc transporter), member 8 |
|
increases transport |
ISO |
7 |
88,583,770 |
88,617,145 |
RGD:6480464 |
CTD |
| G |
Slc30a8 |
solute carrier family 30 (zinc transporter), member 8 |
|
increases uptake |
ISO |
7 |
88,583,770 |
88,617,145 |
RGD:6480464 |
CTD |
| G |
Slc30a9 |
solute carrier family 30 (zinc transporter), member 9 |
|
increases transport |
ISO |
14 |
43,423,677 |
43,477,106 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
increases transport |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
decreases expression |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
affects metabolic processing |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
affects expression |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
increases transport |
ISO |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
multiple interactions |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
decreases expression |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
increases uptake |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
increases expression |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
multiple interactions |
ISO |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
|
increases transport |
ISO |
10 |
102,863,399 |
103,189,081 |
RGD:6480464 |
CTD |
| G |
Slc39a12 |
solute carrier family 39 (zinc transporter), member 12 |
|
increases transport |
ISO |
17 |
88,525,527 |
88,605,947 |
RGD:6480464 |
CTD |
| G |
Slc39a13 |
solute carrier family 39 (zinc transporter), member 13 |
|
increases transport |
ISO |
3 |
75,421,153 |
75,429,058 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
affects import |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
increases uptake |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
increases transport |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
affects expression |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a2 |
solute carrier family 39 (zinc transporter), member 2 |
|
increases transport |
ISO |
15 |
27,328,308 |
27,330,420 |
RGD:6480464 |
CTD |
| G |
Slc39a2 |
solute carrier family 39 (zinc transporter), member 2 |
|
increases expression |
EXP |
15 |
27,328,308 |
27,330,420 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
increases transport |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
affects metabolic processing |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
affects expression |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
multiple interactions |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
increases transport |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
increases uptake |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
decreases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
affects expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
decreases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a5 |
solute carrier family 39 (metal ion transporter), member 5 |
|
increases transport |
ISO |
7 |
1,686,969 |
1,692,393 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (zinc transporter), member 6 |
|
increases transport |
ISO |
18 |
16,353,725 |
16,374,267 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (zinc transporter), member 6 |
|
multiple interactions |
ISO |
18 |
16,353,725 |
16,374,267 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (zinc transporter), member 6 |
|
decreases expression |
ISO |
18 |
16,353,725 |
16,374,267 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (zinc transporter), member 6 |
|
affects expression |
EXP |
18 |
16,353,725 |
16,374,267 |
RGD:6480464 |
CTD |
| G |
Slc39a7 |
solute carrier family 39 (zinc transporter), member 7 |
|
increases transport |
ISO |
20 |
4,961,280 |
4,964,652 |
RGD:6480464 |
CTD |
| G |
Slc39a7 |
solute carrier family 39 (zinc transporter), member 7 |
|
decreases expression |
ISO |
20 |
4,961,280 |
4,964,652 |
RGD:6480464 |
CTD |
| G |
Slc39a7 |
solute carrier family 39 (zinc transporter), member 7 |
|
increases expression |
ISO |
20 |
4,961,280 |
4,964,652 |
RGD:6480464 |
CTD |
| G |
Slc39a7 |
solute carrier family 39 (zinc transporter), member 7 |
|
decreases expression |
ISO |
20 |
4,961,280 |
4,964,652 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
increases transport |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
decreases expression |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc39a9 |
solute carrier family 39 (zinc transporter), member 9 |
|
increases transport |
ISO |
6 |
104,407,151 |
104,442,633 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
increases expression |
ISO |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions |
ISO |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Snai2 |
snail family zinc finger 2 |
|
affects binding |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
multiple interactions |
ISO |
3 |
124,806,637 |
124,894,653 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
multiple interactions |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects binding |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects binding |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects binding |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
affects binding |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spice1 |
spindle and centriole associated protein 1 |
|
decreases expression |
ISO |
11 |
57,836,725 |
57,878,435 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
decreases activity |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
increases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
St5 |
suppression of tumorigenicity 5 |
|
increases expression |
ISO |
1 |
167,119,711 |
167,284,482 |
RGD:6480464 |
CTD |
| G |
Sulf1 |
sulfatase 1 |
|
increases expression |
EXP |
5 |
5,582,896 |
5,748,106 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Taf15 |
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
multiple interactions |
ISO |
10 |
71,555,890 |
71,587,919 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects binding |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
increases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
EXP |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Thpo |
thrombopoietin |
|
multiple interactions |
ISO |
11 |
82,412,552 |
82,417,807 |
RGD:6480464 |
CTD |
| G |
Timm17a |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
multiple interactions |
ISO |
13 |
48,297,516 |
48,309,303 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tlr6 |
toll-like receptor 6 |
|
multiple interactions |
ISO |
14 |
46,089,365 |
46,100,687 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects abundance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
affects expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
multiple interactions |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnnt2 |
troponin T type 2 (cardiac) |
|
multiple interactions |
ISO |
13 |
48,872,972 |
48,885,815 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects folding |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects binding |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp73 |
tumor protein p73 |
|
multiple interactions |
ISO |
5 |
170,848,979 |
171,078,739 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects binding |
ISO |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
decreases expression |
EXP |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Tra2a |
transformer 2 alpha homolog (Drosophila) |
|
decreases expression |
ISO |
4 |
77,372,546 |
77,391,417 |
RGD:6480464 |
CTD |
| G |
Trhde |
thyrotropin-releasing hormone degrading enzyme |
|
multiple interactions |
ISO |
7 |
53,591,770 |
54,021,219 |
RGD:6480464 |
CTD |
| G |
Trove2 |
TROVE domain family, member 2 |
|
decreases expression |
ISO |
13 |
57,584,656 |
57,605,648 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
multiple interactions |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tufm |
Tu translation elongation factor, mitochondrial |
|
affects binding |
ISO |
1 |
185,631,333 |
185,634,940 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd3 |
thioredoxin reductase 3 |
|
multiple interactions |
ISO |
4 |
123,730,278 |
123,771,572 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Unc119 |
UNC-119 homolog (C. elegans) |
|
affects expression |
ISO |
10 |
64,285,993 |
64,291,392 |
RGD:6480464 |
CTD |
| G |
Unc119 |
UNC-119 homolog (C. elegans) |
|
increases expression |
ISO |
10 |
64,285,993 |
64,291,392 |
RGD:6480464 |
CTD |
| G |
Use1 |
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
16 |
18,528,286 |
18,530,994 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
decreases expression |
EXP |
16 |
40,624,435 |
40,739,692 |
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
multiple interactions |
ISO |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
affects expression |
EXP |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
affects expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Wdr46 |
WD repeat domain 46 |
|
decreases expression |
ISO |
20 |
5,089,611 |
5,097,383 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects binding |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
multiple interactions |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
multiple interactions |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
multiple interactions |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects binding |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects binding |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects binding |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
affects expression |
ISO |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
multiple interactions |
ISO |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
multiple interactions |
ISO |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
increases expression |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
Term paths to the root
|